Product Information
IRBESARTAN 150 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1111 per EA under NDC 43547037550. Its NADAC has been published 501 times since Nov 23, 2016.
Strength
150 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547037550
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203071On Market Since
6/13/2016
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 150 MG TABLET has been published 501 times since Nov 23, 2016, and over the history we have for it it has declined 35.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1111 per EA |
|---|---|
| All-time high | $0.3249 (Oct 16, 2019) |
| All-time low | $0.0990 (Nov 20, 2024) |
| 52-week high | $0.1237 |
| 52-week low | $0.1103 |
| Median price | $0.1587 |
| Average price | $0.1747 |
| Largest weekly change | +25.9% (Jun 19, 2024) |
| Weeks tracked | 501 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 150 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1111 per EA (NDC 43547037550), effective Jun 24, 2026.
How has the price of IRBESARTAN 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 150 MG TABLET has declined 35.4%. It has been tracked across 501 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 150 MG TABLET?
Since Nov 23, 2016, the NADAC for IRBESARTAN 150 MG TABLET has ranged from a low of $0.0990 (Nov 20, 2024) to a high of $0.3249 (Oct 16, 2019), with a median of $0.1587 per EA.
Are there cheaper alternatives to IRBESARTAN 150 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 150 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 150 MG TABLET?
IRBESARTAN 150 MG TABLET (NDC 43547037550) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification